论文部分内容阅读
目的讨论原发性高血压伴稳定型心绞痛中硝苯地平控释片的临床效果。方法 124例高血压伴稳定型心绞痛的患者为研究对象,根据治疗方式不同分为常规组和治疗组,每组62例。常规组给予硝酸异山梨酯片联合厄贝沙坦分散片治疗,治疗组给予硝苯地平控释片联合厄贝沙坦分散片治疗。观察比较两组的治疗效果、心绞痛发作时间和发作次数。结果常规组的总有效率为82.26%,治疗组的总有效率为95.16%,比较差异具有统计学意义(P<0.05)。治疗组患者的心绞痛发作时间为(2.4±1.1)min、发作次数为(1.3±0.6)次/周,均明显少于常规组的(2.8±1.1)min、(2.4±0.8)次/周,差异具有统计学意义(P<0.05)。结论硝苯地平控释片治疗原发性高血压伴稳定型心绞痛的效果较为理想,可以有效的缓解患者的临床症状,降低不良反应发生率,具有安全、可靠等优点。
Objective To discuss the clinical effect of controlled release nifedipine in patients with essential hypertension and stable angina pectoris. Methods One hundred and twenty-four patients with hypertension and stable angina pectoris were divided into two groups: conventional group and treatment group, with 62 cases in each group. The conventional group was given isosorbide mononitrate tablets combined with irbesartan dispersible tablets, the treatment group was given nifedipine controlled release tablets combined with irbesartan dispersible tablets. Observation and comparison of two groups of treatment, angina pectoris time and number of attacks. Results The total effective rate of the conventional group was 82.26%, the total effective rate of the treatment group was 95.16%, the difference was statistically significant (P <0.05). The duration of angina pectoris in the treatment group was (2.4 ± 1.1) min and the number of episodes was (1.3 ± 0.6) / week, which were significantly lower than those in the conventional group (2.8 ± 1.1) min and (2.4 ± 0.8) The difference was statistically significant (P <0.05). Conclusion Nifedipine GITS is effective in treating patients with essential hypertension and stable angina pectoris, which can effectively relieve the clinical symptoms and reduce the incidence of adverse reactions. It is safe and reliable.